(Q43629336)

25 November 2017

title

Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudine (English)

1 reference

25 November 2017

1 reference

1

1 reference

25 November 2017

3

1 reference

25 November 2017

10

1 reference

25 November 2017

12

1 reference

25 November 2017

Santantonio T

2

1 reference

25 November 2017

Insalata M

4

1 reference

25 November 2017

Facciorusso D

5

1 reference

25 November 2017

Signorile F

6

1 reference

25 November 2017

Perri F

7

1 reference

25 November 2017

Guastadisegni A

8

1 reference

25 November 2017

Gioffreda D

9

1 reference

25 November 2017

Pastore G

11

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Alimentary Pharmacology & Therapeutics

25 November 2017

published in

1 reference

25 November 2017

volume

18

1 reference

25 November 2017

issue

9

1 reference

25 November 2017

page(s)

933-940

1 reference

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01787.X

10.1046/J.1365-2036.2003.01787.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference